Welcome to Bluestone

At Bluestone, we conduct phase I through phase IV clinical trials in medical and dental research with a focus on oral health.

As a state-of-the-art, full service clinical research facility, Bluestone has the space, people and expertise to accommodate all the needs of our clients.


Bluestone Newsroom

NYU Dentistry's Dr. Nicole N. Scheff Receives $120,000-Plus NIDCR F32 Grant to Investigate the Biology of Sex Differences in Oral Cancer Pain

New York - 2017-07-07. Nicole Scheff, PhD, a postdoctoral fellow in the laboratory ofDr. Brian L. Schmidt, director of the ... Continue...

Drs. Brian Schmidt and Seiichi Yamano Awarded $1.2M from NIH to Investigate Gene Delivery for the Treatment of Oral Cancer Pain

New York - 2016-06-14. The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institute... Continue...

NYU and UCLA Awarded $2.4M from NIH to Further Study the Use of Non-Psychotropic Cannabinoids to Suppress Chronic Cancer Pain

New York - 2016-01-26. Dr. Brian Schmidt and Dr. Igor Spigelman will focus on the therapeutic utility of recently develope... Continue...

Sponsors / Investigators

Let us help you succeed

Participate in a Trial

Help advance patient care

Current Bluestone Trials

Find out which clinical trials are open for enrollment